Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. March 2022, section EUDA news
18. June 2026 EUDA annual activity report 2025: first full year under expanded mandate The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the...